Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma

Analgosedation practice during noninvasive respiratory supports: Results from an Italian survey.

Journal of critical care·2025

Management of analgosedation during noninvasive respiratory support: an expert Delphi consensus document developed by the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI).

Journal of anesthesia, analgesia and critical care·2024

A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium.

ESMO open·2024

Development of clinical tools to estimate the breathing effort during high-flow oxygen therapy: A multicenter cohort study.

Pulmonology·2024

Agricultural drift depositional simulation of a copper-based fungicide and its effects on non-target terrestrial and freshwater compartments.

Ecotoxicology (London, England)·2023

The prevalence of celiac disease and the appropriateness of the diagnosis in family medicine setting could be lower than expected.

European review for medical and pharmacological sciences·2022

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Progress in the Study of B-Cell Immune Metabolic Regulation Mechanisms in Exercise-Induced Fatigue: A Narrative Review.

Metabolites·2026

Distinct clinical associations of baseline and treatment-emergent hypogammaglobulinemia in diffuse large B-cell lymphoma: a retrospective real-world cohort study.

Annals of hematology·2026

Serum Free Light Chains in Lymphoma: A Phenotype-First Framework for Biological Interpretation, Analytical Control, and Clinical Use.

Current oncology (Toronto, Ont.)·2026

Circulating immune cells phenotypes discriminate bipolar disorder from major depressive disorder during a depressive episode: A machine learning elastic-net approach.

Journal of affective disorders·2026

When Every Test Fails: Multifocal Grade 1 Ileal Neuroendocrine Tumors Causing Transfusion-Dependent Obscure Overt Gastrointestinal Bleeding.

ACG case reports journal·2026

Identification of Amino Acid Residues, Distal to the Peptide-Binding Domain, That Confer Serological Distinctions Within Each HLA-DQB102, 03, 05 and 06 Antigen Group.

HLA·2026

Related Experiment Videos

Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma

Related Concept Videos

Analgosedation practice during noninvasive respiratory supports: Results from an Italian survey.

Management of analgosedation during noninvasive respiratory support: an expert Delphi consensus document developed by the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI).

A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium.

Development of clinical tools to estimate the breathing effort during high-flow oxygen therapy: A multicenter cohort study.

Agricultural drift depositional simulation of a copper-based fungicide and its effects on non-target terrestrial and freshwater compartments.

The prevalence of celiac disease and the appropriateness of the diagnosis in family medicine setting could be lower than expected.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Progress in the Study of B-Cell Immune Metabolic Regulation Mechanisms in Exercise-Induced Fatigue: A Narrative Review.

Distinct clinical associations of baseline and treatment-emergent hypogammaglobulinemia in diffuse large B-cell lymphoma: a retrospective real-world cohort study.

Serum Free Light Chains in Lymphoma: A Phenotype-First Framework for Biological Interpretation, Analytical Control, and Clinical Use.

Circulating immune cells phenotypes discriminate bipolar disorder from major depressive disorder during a depressive episode: A machine learning elastic-net approach.

When Every Test Fails: Multifocal Grade 1 Ileal Neuroendocrine Tumors Causing Transfusion-Dependent Obscure Overt Gastrointestinal Bleeding.

Identification of Amino Acid Residues, Distal to the Peptide-Binding Domain, That Confer Serological Distinctions Within Each HLA-DQB102, 03, 05 and 06 Antigen Group.

Related Experiment Videos

Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma

Related Concept Videos

Related Articles